Curevac: In command of finance

German mRNA company Curevac AG has appointed Pierre Kemula as Chief Financial Officer. Kemula joins Curevac from medtech firm Pixium Vision, where he was also responsible for financial activities.

During his tenure as CFO of Pixium Vision, Kemula was instrumental in the company’s Euronext IPO. After receiving his degree in Management Sciences from the London School of Economics, he began his carreer in consulting with companies such as Roland Berger, Gemini Consulting and KPMG. Before joining Pixium, he held the position of VP Corporate Finance, Treasury and Financial Markets with specialty pharma company Ipsen.